• Volume 70 , Number 2
  • Page: 111–8

Contrary to BCG, MLM fails to induce the production of TNFα and NO by macrophages

Oscar Rojas-Espinosa1; Kendy Wek-Rodriguez2; Patricia Arce-Paredes3; Fabiola Aguilar-Torrentera4; Carine Truyens4; Yves Carlier5


Pathogenic mycobacteria must possess efficient survival mechanisms to resist the harsh conditions of the intraphagosomal milieu. In this sense, Mycobacterium lepraemurium (MLM) is one of the most evolved intracellular parasites of murine macrophages; this microorganism has developed a series of properties that allows it not only to resist, but also to multiply within the inhospitable environment of the phagolysosome. Inside the macrophages, MLM appears surrounded by a thick lipid-envelope that protects the microorganism from the digestive effect of the phagosomal hydrolases and the acid pH. MLM produces a disease in which the loss of specific cellmediated immunity ensues, thus preventing activation of macrophages. In vitro, and possibly also in vivo, MLM infects macrophages without triggering the oxidative (respiratory burst) response of these cells, thus preventing the production of the toxic reactive oxygen intermediaries (ROI). Supporting the idea that MLM is within the most evolved pathogenic microorganisms, in the present study we found, that contrary to BCG. M. lepraemurium infects macrophages without stimulating these cells to produce meaningful levels of tumor necrosis factor alpha (TNFα) or nitric oxide (NO). Thus, the ability of the microorganisms to stimulate in their cellular hosts, the production of ROI and RNI (reactive nitrogen intermediates), seems to be an inverse correlate of their pathogenicity; the lesser their ability, the greater their pathogenicity.


Les mycobactéries pathogènes doivent posséder des mécanismes de survie efficaces pour résister aux conditions hostiles du milieu intraphagosomal. En ce sens. M. lepraemurium (MLM) est un des parasites intracellulaires les plus évolués des macrophages des souris. Ce microorganisme a développé une série de propriétés qui lui permettent 11011 seulement de résister, mais aussi de se multiplier dans l'environnement inhospitalier du phagolysosome. Dans les macrophages, MLM apparaít entouré par une épaisse enveloppe lipidique qui le protège d'une digestion par des hydrolases phagosomales et du pH acide. MLM induit un déficit de l'immunité cellulaire en évitant l'action des macrophages. Par ailleurs, in vitro, et probablement aussi in vivo. MLM infecte les macrophages sans déclencher leur réponse oxydative, prévenant de cette manière la production de dérivés toxiques de l'oxygène. De plus, contrairement à  BCG, M. lepraemurium infecte les macrophages sans induire la production de quantités significatives de tumeur necrosis facteur alpha (TNFα) ou d'oxyde nitrique (NO) (cf. cet article). Les dérivés de l'oxygène et l'oxyde nitrique étant les armes les plus efficaces des macrophages, il est clair que M. lepraemurium est un des parasites les plus évolués et done les plus pathogènes pour les macrophages.
Acknowledgment. This investigation is part of a Research Program on Leprosy supported by the Consejo Nacional de Ciência y Tecnología, México (Projects 26427-M "La lepra murina como modelo de estudio de la lepra humana" and 38441-M "Las citocinas y su relación con la evolución de la lepra en un modelo animal: lepra murina)" and by the Coordinación General de Posgrado e Investigación (CGPI) del (Project 32.12: "Inmunidad celular y humoral en la lepra murina: un estudio cinético"). O. Rojas-Espinosa holds fellowships from SNI (Mex.), COFAA (IPN) and BDI (IPN): P. Arce-Paredes is a fellow holder of COFAA and BDD: K. Wek-Rodríguez is a fellow of CONA- CyT.


Las micobacterias patógenas deben poseer eficientes mecanismos de supervivencia para resistir las condiciones agresivas del medio intrafagosomal. En este sentido. Mycobacterium lepraemurium (MLM) es uno de los parásitos más evolucionados de los macrófagos murinos: este organismo ha desarrollado una serie de propiedades que le permiten no solo resistir, sino también proliferar dentro del inhóspido medio del fagolisosoma. Dentro de los macrófagos, MLM aparece rodeado de una gruesa envoltura lipídica que lo protege del efecto digestivo de las hidrolasas fagosomales y del pH ácido de la vacuola. MLM produce una enfermedad en la cual ocurre la perdida de la inmunidad celular específica, evitando así la activación de los macrófagos. ln vitro, y probablemente también in vivo, MLM infecta a los macrófagos sin estimular la respuesta oxidativa (estallido respiratorio) de estas células, evitando de esta mariera la production de los intermediarios tóxicos del oxígeno. Además, contrario a lo que ocurre con BCG. M. lepraemurium infecta a los macrófagos sin estimular la capacidad de estas células para producir niveles significativos de factor de necrosis tumoral alfa (TNFα) o de óxido nítrico (NO) (esta comunicación). Siendo los metabolitos reactivos del oxígeno, y el óxido nítrico, las armas más letales de los macrófagos, es claro que M. lepraemurium está dentro de los parásitos más evolucionados, y por ende, patogénicos de los macrófagos.

In a previous paper we have qualified Mycobacterium lepraemurium as a highly evolved parasite of mouse macrophages (32). We based this statement on the following three properties of the bacillus: a) it is a fusiogenic microorganism adapted to live within the harsh environment of the phagolysosome (5, 11), b) it is protected by a thick and complex lipid envelope (12), and c) it enters the macrophage without triggering the oxidative (microbicidal) response of this cell (32). In this communication we offer further evidence on the qualities of M. lepraemurium that make this microorganism a highly successful parasite of macrophages. Macrophages possess several powerful microbicidal mechanisms, that acting together help these cells to get rid of the majority of the ingested microorganisms. Within these microbicidal mechanisms of macrophages are the generation of reactive oxygen intermediates (ROI) (34) and reactive nitrogen intermediates (RN1) (22,23), as well as the presence of certain pore-forming cationic proteins (39). As for the role of the hydrolytic lysosomal enzymes, except for lysozyme, they seem to be mainly digestive rather than microbicidal (19).

Although the microbicidal capacity of macrophages is up regulated by the effect of cell mediated immunity exerted mainly, but not solely, through gamma interferon produced by TCD4+ cells (21, 28), macrophages themselves are able to produce ROI and RNI, and the RNI-related cytokine tumor necrosis factor alpha (TNFα), in response to the in vitro infection with several microorganisms (40, 42). Infection of murine macrophages by BCG and other intracellular parasites, leads to production and release of significant amounts of TNFα. This cytokine up-regulates the synthesis of nitric oxide synthase which, in turn, activates the metabolism of arginine to produce nitric oxide (14, 16, 37). Both the nitric oxide produced through this pathway and the ROI produced through the respiratory burst pathway (13, 20, 27, 34), or a combination of both (), contribute to the killing of BCG and other intracellular microorganisms, as do the free fatty (arachidonic and linolenic) acids produced by macrophages (1). In this communication we report the effect of the infection of mouse macrophages with M. lepraemurium on the synthesis and release of TNFα and nitric oxide, and compare the results with those observed upon infection of macrophages with M. bovis BCG. To our knowledge, this is the first study on the synthesis and release of TNFα and NO, following the in vitro infection of non-immune murine macrophages with M. lepraemurium.



Chemicals. Except when indicated, chemicals were from Sigma Chemical Co., St. Louis, Missouri, U.S.A., and cell culture media and supplements were from Invitrogen. Grand Island, New York, U.S.A.

Bacilli. M. lepraemurium bacilli were freshly isolated from the spleen and liver of NIH mice bearing a 6-month infection with the microorganism. Purification of bacilli was carried out by following the entire procedure of Prabhakharan (29) and the Fercoll step of Draper's method (10) in that order. These methods have been used to isolate bacilli from human or armadillo tissues infected with M. leprae. The procedure, as applied to M. lepraemurium, has been described in detail elsewhere (32). This allowed us to have a very clean suspension of MLM that was adjusted (by using a reference curve prepared with variable amounts of bacilli) to contain 25 x 108 bacilli per ml of PBS (0.01 M phosphate in 0.15 M NaCl, pH 7.4). Bacilli were then collected by centrifugation (6,000 rpm/20 min), suspended to the original volume with tissue culture medium (MEM supplemented with 10% fetal calf serum, amino acids and gentamicin), divided into 1 ml aliquots, and then kept frozen at -20ºC until used. Bacilli were used within 60 days of their preparation. Mycobacterium bovis BCG (Danish strain) was obtained from the National Institute of Hygiene at Mexico City as a lyophilized vaccine freshly produced. Several ampules of BCG vaccine were reconstituted in pyrogen-free distilled water, diluted with PBS to prepare a suspension containing 25 x 108 bacilli per ml, centrifuged, suspended in MEM-FCS, divided into aliquots and kept frozen at -20ºC until used, usually within the following two months.

Macrophages collection and culture. Macrophages were collected from the peritoneal cavity of uninfected, female retired breeder BALB/c mice, intraperitoneally injected with 1.0 ml of sterile mineral oil, 4 days before cell harvesting; this procedure does not seem to metabolically activate macrophages (32). The collection of macrophages was carried out as described elsewhere (32), and cell suspensions were prepared to contain 5 x 105 mononuclear cells per ml. Cell cultures were prepared by "seeding" 5 x 105 cells in 200 μl of MEM-FCS per well in 96-well culture plates, and the cultures infected with M. lepraemurium or BCG, as described below.

Infection of cultures with Mycobacterium lepraemurium or BCG. Triplicate culture wells were then treated with 10 μl of culture medium (control cultures), 10 μl of Mycobacterium bovis BCG (25 x 106 bacteria per well) or 10 μl of M. lepraemurium (25 x 106 bacilli per well). Then cultures were sampled at 24 hrs and 48 hrs to assess the release of tumor necrosis factor (TNF) and nitric oxide (NO). Culture supernatants were removed at 24 hrs and replaced with fresh MEM-FCS medium. Forty-eight-hr supernatants were collected 24 hrs later (representing TNF and NO production 24 hr-48 hr after infection). Some mycobacteria-infected macrophage cultures were stained by the carbol-fuchsin method of Ziehl-Neelsen to estimate the degree of infection with each mycobacteria.

Measurement of TNFα. TNFα secretion was assessed by using a commercial enzyme linked immunosorbent assay (ELISA) kit (RPN 2718 Biotrak, Amersham, England), following the manufacturers' protocol. TNFα concentration in the samples is calculated from standard curves prepared with reference solutions containing known amounts of TNFα (2450 pg/ml, 350 pg/ml and 50 pg/ml).

Measurement of nitric oxide. Nitric oxide was determined by the Griess reaction (l5, 25) in supernatants of macrophage cultures infected for 24 hrs or 48 hrs with MLM or BCG. Fifty microliters of supernatants were admixed with 200 μl of the Griess reagent and the absorbence of the resulting colored product, read in a colorimeter (Multiskan-plus ELISA reader) at 540 nm. Readings were transformed into ng of nitrite by reference to a standard curve ranging from 0 to 100 ng of sodium nitrite (Griess reagent is a volume to volume mixture of 1% sulfanilamide in water and 0.1 % N-[1-naphthyl] ethylendiamine-2HCl in 2.5% phosphoric acid).

Analysis of results. Data were subjected to an analysis of variance (ANOVA), and then to the Mann-Whitney test.



Tumor necrosis factor alpha (TNFα). Macrophages released large amounts of TNFα in response to the in vitro infection with BCG (710 ± 371.6 picograms [pg] per 0.5 x 106 cells, versus 78.3 ± 18.9 pg in the control cells, p <0.001) but did not release this cytokine in response to MLM (61.6 ± 25.6 pg per 0.5 x 106 cells versus 78.3 ± 18.9 pg, p >0.100). Most of this cytokine was produced within the 24 hrs following stimulation with BCG (710 ± 371 pg versus 456.6 ± 189.2 pg at 48 hrs). The results of three experiments carried out with different animal groups are shown in Table 1.



Nitric oxide. The pattern of release of NO was similar to the pattern of release of TNFα: macrophages responded well to the infection by BCG (322.6 ± 103 nanograms [ng] per 0.5 x 106 cells, versus 29.3 ± 2.3 ng in the cells alone, p <0.001) and not at all to the stimulus with MLM (30.6 ± 2.3 ng versus 29.3 ± 2.3 ng, p >0.100). Again, most NO was produced within the first 24 hrs following the stimulus with BCG (322.6 ± 103 ng versus 209.3 ± 37.2 ng at 48 hrs).
The results of three independent experiments are shown in Table 2.



The average simultaneous production of TNFα and NO by macrophages infected by BCG or MLM is illustrated in Fig. 1. The production of TNFα and synthesis of NO seem to be directly related.


Fig. 1. Simultaneous production of TNFα and NO by macrophages infected in vitro with M. bovis (BCG) or M. lepraemurium (MLM). Only the average levels of these factors are depicted. The shadowed area corresponds to the response in the cultures of macro-phages not subjected to infection.


Macrophage infection. Macrophages got infected to a similar degree with either MLM or BCG, although a somehow different intracellular distribution of each of the mycobacteria was observed; BCG appeared more clumpy than MLM, either because of the normal clumpy growth of BCG on artificial media, or, perhaps, because it has a different entry mechanism into macrophages (Fig. 2). An investigation on this latter possibility is currently underway.


Fig. 2. Cultured macrophages infected for 24-hr with M. bovis (BCG) (A, B) or M. lepraemurium (MLM) (C, D). Infection was performed with a theoretical ratio of 50 bacilli per cell. Notice that although similar numbers of bacilli entered the cells, BCG bacilli appear more clumpy than MLM.



The link between IFNg produced by T cells and NK cells and TNFα and NO produced by macrophages, has been observed in several infectious diseases and has been sought as a key mechanism of macrophages for the killing of intracellular microorganisms, whether pathogenic or not (37, 14, 38, 35).
Macrophages, however, are able to produce TNFα (31, 41, 42) and NO (40) in response to the in vitro infection with certain microorganisms, such as M. hovis BCG, in the absence of T cells, this ruling out the absolute requirement of cell-mediated immunity for macrophage activation. However, T cell-derived cytokines, namely IFNg, do indeed improve the microbicidal ability of macrophages by up-regulating the activity of the genes coding for TNFα and nitric oxide synthase (iNOS), a process leading to an overwhelming synthesis of nitric oxide (14). Apart from being a chemical mediator, nitric oxide is a key participant in the killing of intracellular microorganisms and is an alternative mechanisms for the killing of ROI-resistant parasites. Those microorganisms that resist the microbicidal mechanisms of macrophages represented by the reactive oxygen-intermediaries (superoxide anion, hydrogen peroxide, hydroxy radicals), the reactive nitrogen intermediaries (nitric oxide), the combined myeloperoxidase-hydrogen peroxide-halide system, and the non oxygen-dependent hydrolytic and pore-forming lysosomal enzymes, are indeed parasites whose physiological elimination would require the participation of cell mediated immunity, through a plethora of proinflammatory cytokines produced by T lymphocytes and other cells (7, 8, 9, 17, 28, 30). Although susceptible to the in vitro inhibitory effect of these cytokines, some microorganisms, such as M. lepraemurium and M. leprae, are, however, "intelligent enough" to prevent overeactivation of macrophages by directly or indirectly suppressing or down-regulating the activity of the mycobacteria-reactive, macrophage activating, T cell clones (2, 3).

In this communication, we present evidence on the ability of M. lepraemurium to in vitro infect mouse macrophages, without triggering a meaningful TNFα /NO-response of these cells. Mycobacterium bovis BCG, on the other hand, behaves in a very different manner because it is a good inducer of both TNFα and NO. The particular behavior of these mycobacteria is in tight correlation with their pathogenicity, because it has been seen that as many as 50 million BCG cells produce in NIH mice an early but self-limiting disease. Forty days after infection, only residual, inactive, bacilli-free scar-like lesions are observed in the target (liver and spleen) organs of mice intraperitoneally infected with this high dose of bacilli. On the other hand, as few as 5 million (Rojas-Espinosa, unpublished), or less (36), M. lepraemurium cells, produced in the mouse a disseminated lepromatous disease that was clearly evident, several months after infection by the same route.

The ability of M. lepraemurium to emerge as a very successful parasite of macrophages depends on the development of a series of attributes of the bacteria that include: a) the synthesis of a thick and complex lipid envelope (12), b) its ability to survive within the inhospitable intraphagosomal environment, a property probably related to the previous one (5, 11), c) its ability to infect macrophages without triggering these cells' oxidative response (32), d) its ability to infect macrophages without triggering the release of significant amounts of tumor necrosis factor or nitric oxide (Rojas-Espinosa. et al., this communication), e) its ability to produce a disease in which cell anergy gradually develops (4), and f) its ability to produce a disease in which complement is inactivated, thus preventing complement-mediated damage of the host (33).

As the degree of macrophage infection by M. lepraemurium is apparently similar to the degree of infection by BCG (Fig. 2), the different response of macrophages to the infection with these microorganisms, in terms of TNFα, ROI and RNI release, must have another explanation. Based on preliminary evidence of different protein-phosphorylation patterns in macrophages infected with M. lepraemurium or BCG, we believe that the results reflect different entry pathways of the microorganisms. This subject is under research in our laboratory.



1. Akaki. T., Sato, K., Shimizu, T., Sano, C., Kajitani, H., Dekio, S. and Tomioka, H. Effector molecules in expression of the antimicrobial activity of macrophages against Mycobacterium avium complex: roles of reactive nitrogen intermediates, reactive oxygen intermediates, and free fatty acids. J. Leukoc. Biol. 62 (1997) 795-804.

2. Akiyama, T., Esashika, I. and Yamamura, N. Suppressor cells in experimental murine leprosy. Int. J. Lepr. 50 (1982) 595-597.

3. Bach. M. A., Hoffenbach, A. Lagrange. P. H., Wallach, D. and Cottenot, F. Mechanisms of T- cell unresponsiveness in leprosy. Ann. Immunol, (inst Pasteur) 134D (1983) 75-84.

4. Brett, S. J. T-cell responsiveness in Mycobacterium lepraemurium infections in a "resistant" (CBA) and a "susceptible" (BALB/c) mouse strain. Cell Immunol. 89 (1984) 132- 143.

5. Brown, C. A., Draper, P. and D'Arcy-Hart, P. Mycobacteria and lysosomes: a paradox. Nature 221 (1969)658-660.

6. Chan, J., Yun. X., Magliozzo, R. S. and Bloom, R. B. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175(1992) 1111-1122.

7. Denis. M. Cytokine modulation of Mycobacterium lepraemurium infection in mice: important involvement of tumor necrosis factor alpha, interleukin-2 and dissociation from macrophage activation. Int. J. Immunopharmacol. 13 (1991) 889-895.

8. Denis, M. Cytokine modulation of Mycobacterium lepraemurium growth in murine macrophages: beneficial effect of tumor necrosis factor alpha and granulocyte-macrophage colony-stimulating factor. Infect. Immun. 59 (1991) 705-707.

9. Denis, M. Recombinant interleukin-1 infusion increases resistance of BALB/c mice to murine leprosy. Int. J. Pharmacol. 13 (1991) 897-902.

10. Draper, D. Purification of Mycobacterium leprae. Report of the Fifth Meeting of the Scientific Working Group on the Immunology of Leprosy. Geneva, 24-26 June (1980). TDR/IMMLEP-SWG 5/80.3.

11. Draper. P. and D'Arcy-Hart, P. Phagosomes, lysosomes and mycobacteria: cellular and microbial aspects. In: Mononuclear phagocytes in immunit, infection, and pathology. Van Furth. R. London: Blackwell Scientific Publications. 1975, pp. 575-594.

12. Draper, P. and Rees, R. J. W. The nature of the electron-transparent that surrounds Mycobacterium lepraemurium inside host cells. J. Gen. Microbiol. 77 (1973) 79-87.

13. Fazal. N. The effect of NG-monomethyl-L-arginine (LNMMA), an NO-synthase blocker on the survival of intracellular BCG within human monocyte-derived macrophages. Biochem. Mol. Biol. Int. 40(1996) 1033-1046.

14. Frankova, D. and Zidek, Z. IFNg-induced TNFα is a prerequisite for in vitro production of nitric oxide generated in murine peritoneal macrophages by IFNg. Fur. J. Immunol. 28 (1998) 838-843.

15. Green, L. C., Wagner. D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S. and Tannenbaum, S. R. Analysis of nitrate, nitrite and (15n) nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138.

16. Green, S. J., Scheller. L. F., Marletta, M. A., Seguin, M. C., Klotz. F. W., Slayter, M., Nelson, B. J. and Nacy, C. A. Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. Immunol. Lett. 43 (1994) 87-94.

17. Jeevan, A. and Asherson, G. L. Recombinant interleukin-2 limits the replication of Mycobacterium lepraemurium and Mycobacterium bovis BCG in mice. Lymphokine Res. 7 (1988) 129-140.

18. Jiang, X., Leonard, B., Benson. R. and Baldwin, C. L. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell. Immunol. 151 (1993) 309-319.

19. Konetsuna, F. Effect of lysozyme on mycobacteria. Microbiol. Immunol. 24 (1980) 1151-1162.

20. Laochumroonvorapong, P., Paul, S., Manca, C., Freedman, V. H. and Kaplan, G. Mycobacterial growth and sensitivity to H2O2 killing in human monocytes in vitro. Infect. Immun. 65 (1997) 4850-4857.

21. Le Page, C., Genin, P., Baines, M. G. and Hiscott. J. Interferon activation and innate immunity. Rev. Immunogenet. 2 (2000) 374-386.

22. Liew, F. Y. The role of nitric oxide in parasitic diseases. Am. Trop. Med. Parasitol. 87 (1993) 637-642.

23. Liew, F. Y. and Cox, F. E. G. Nonspecific defence mechanisms: the role of nitric oxide. Immunol. Today 12 (1991) A17-A21.

24. Linares, E., Giorgio. S., Mortara, R. A., Santos, C. X., Yamada, A. T. and Augusto. O. Role of peroxynitrite in macrophage microbicidal mechanisms in vivo revealed by protein nitration and hydroxylation. Free Radic. Biol. Med. 11 (2001)1234-1242.

25. Migliorini. P., Corradin, G. and Corradin, S. B. Macrophage NO2 production as a sensitive and rapid assay for the quantitation of murine IFNg. J. Immunol. Meth. 139(1991) 107-114.

26. Nozaki, Y., Hasegawa. Y., Ichiyama. S., Nakashima, I. and Shimokata, K. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect. Immun. 65(1997)3644-3647.

27. Paulnock, D. M., Demick, K. P. and Coller, S. P. Analysis of interferon-gamma-dependent and independent pathways of macrophage activation. J. Leukoc. Biol. 67 (2000) 677-682.

28. Petricevich, V. L., and Alves, R. C. Role of cytokines and nitric oxide in the induction of tuberculostatic macrophage functions. Mediators Inflamm. 9 (2000) 261-269.

29. Prabhakaran, K., Harris, E. B. and Kirch- heimer, W. F. Binding of 14C-labeled DOPA by Mycobacterium leprae in vitro. Int. J. Lepr. 44 (1976)58-64.

30. Ramasesh, N., Adams. L. B., Franzblau, S. G. and Krahenbuhl, J. L. Effects of activated macrophages on Mycobacterium leprae. Infect. Immun. 59 (1991) 2864-2869.

31. Reiling. N., Blumenthal, A., Fald, H. D., Ernst, M. and Ehlers, S. Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity. J. Immunol. 167(2001)3339-3345.

32. Rojas-Espinosa, O., Camarena, S. C., Estrada, G. I., Arce-Paredes, P. and Wek, R. K. Mycobacterium lepraemurium. a well adapted parasite of macrophages: 1. Oxygen metabolites. Int. J. Lepr. 66 (1998) 365-373.

33. Rojas-Espinosa, O., Oltra. A., Arce - Paredes, P. and Méndez, P. Inhibition of complement activity in murine leprosy. Int. J. Lepr. 59 (1991) 605-612.

34. Roos, D. The involvement of oxygen radicals in microbicidal mechanisms of leukocytes and macrophages. Klin. Wochenschr. 69 (1991) 975-980.

35. Saito, S. and Nakano, M. Nitric oxide production by peritoneal macrophages of Mycobacterium bovis BCG-infected or non-infected mice: regulatory role of T lymphocytes and cytokines. J. Leukoc. Biol. 59 (1996) 908-915.

36. Silbaq, F., Mor, N., Levy, L. and Bercovier, H. The disease of CBA and BALB/c mice that follows inoculation of a small number of Mycobacterium lepraemurium into the hind foot pad. Int. J. Lepr. 58(1990)681-689.

37. Silva, J. S., Vespa, G. N., Cardoso, M. A., Aliberti, J. C. and Cunha, F. Q. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect. Immun. 63 (1995) 4862 - 1867.

38. Skerret, S. J. and Martin, T. R. Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila. Infect. Immun. 64 (1996) 3236-3243.

39. Spitznagel, J. K. and Shafer, W. M. Neutrophil killing of bacteria by oxygen-independent mechanisms: a historical summary. Rev. Infect. Dis. 7 (1985) 398-403.

40. Thoma-Uszynski. S., Stenger, S., Takeuchi, O., Ochoa, M. T., Engele, M., Sieling, P. A., Barnes, P. F., Rollinghoff, M., Boleskei. P. L., Wagner, M., Akira, S. W., Norgard, M. V., Belisle, J. T., Godowski, P. J., Bloom, B. R. and Modlin, R. L. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291 (2001) 1544-1547.

41. Underhill, D. M., Ozinsky, A., Smith, K. D. and Aderem, A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA. 96 (1999)14459 14463.

42. Valone. S. E., Rich, E. A., Wallis, R. S. and Ellner, J. J. Expression of tumor necrosis factorinvitro by human mononuclear phagocytes stimulated with wholeMycobacteriumbovis BCG and mycobacterial antigens. Infect. Immun. 56 (1998) 3313-3315.











1. Sc.D.
2. Sc.M.
3. B.E.; Department Of Immunology, National School Of Biological Sciences, National Polytechnic Institute, Mexico.
4. Ph.D.
5. M.D.; Laboratoire De Parasitologie, Faculté De Médecine, Université Libre De Bruxelles, Belgium.

Reprint requests to
Dr. O. Rojas-Espinosa
Esuela Nacional De Ciencias Biológicas Del Instituto Politécnico Nacional, Departamento De Inmunología
Carpio Y Plan De Ayala, Colonia Santo Tomás
11340 México, D. F., Mexico
E-mail: rojas_espinosa@hotmail.com

Received for publication on 11 february 2002.
Accepted for publication on 29 may 2002.

2019 © International Journal of Leprosy and other Mycobacterial Diseases all right reaserved GN1